Genmab
Last updated: November 14, 2025
CEO - Jan van de Winkel
Country: Denmark | Funding: $5.7B (+)
Founded: 1999
Website: http://www.genmab.com/
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Founded: 1999
Website: http://www.genmab.com/
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
